| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/neuroimage/ChangASJNME11 |
| P356 | DOI | 10.1016/J.NEUROIMAGE.2011.07.010 |
| P932 | PMC publication ID | 3171637 |
| P698 | PubMed publication ID | 21803164 |
| P5875 | ResearchGate publication ID | 51534455 |
| P50 | author | Eric N Miller | Q56566453 |
| P2093 | author name string | L Chang | |
| T Ernst | |||
| C S Jiang | |||
| H Nakama | |||
| M Andres | |||
| J Sadino | |||
| P2860 | cites work | Cerebellar atrophy associated with human immunodeficiency virus infection | Q45376096 |
| Effects of methamphetamine dependence and HIV infection on cerebral morphology | Q46162061 | ||
| Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients | Q46480624 | ||
| Learning and recall in subjects at genetic risk for Alzheimer's disease | Q46569873 | ||
| APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis | Q48187897 | ||
| The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. | Q48203739 | ||
| APOE genotype and cognitive functioning in a large age-stratified population sample. | Q51908317 | ||
| Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments | Q59053832 | ||
| Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins | Q68921833 | ||
| Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging | Q70514614 | ||
| Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia | Q72340585 | ||
| HIV dementia and apolipoprotein E | Q73428371 | ||
| Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes | Q73704114 | ||
| HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy | Q77407915 | ||
| Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort | Q81095935 | ||
| Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner | Q24292032 | ||
| Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy | Q24631692 | ||
| Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era | Q24632654 | ||
| Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers | Q28271343 | ||
| Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression | Q28284354 | ||
| An improved Bonferroni procedure for multiple tests of significance | Q30050394 | ||
| The human immunodeficiency virus reduces network capacity: acoustic noise effect | Q30494107 | ||
| A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume | Q30970553 | ||
| HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging | Q33583519 | ||
| ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. | Q33758196 | ||
| Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline | Q34098327 | ||
| Lower brain glutamate is associated with cognitive deficits in HIV patients: A new mechanism for HIV‐associated neurocognitive disorder | Q34257820 | ||
| A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. | Q34374878 | ||
| APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors | Q34714286 | ||
| Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing | Q34744492 | ||
| 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry | Q35401301 | ||
| Updated research nosology for HIV-associated neurocognitive disorders | Q35755761 | ||
| Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism? | Q36226653 | ||
| Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: a preliminary study | Q37195984 | ||
| Brain atrophy in HIV infection is more strongly associated with CDC clinical stage than with cognitive impairment. | Q37258806 | ||
| Mapping cerebellar degeneration in HIV/AIDS | Q37268035 | ||
| Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse | Q37314434 | ||
| Declined neural efficiency in cognitively stable human immunodeficiency virus patients | Q37325321 | ||
| Human immunodeficiency virus downregulates podocyte apoE expression | Q37337364 | ||
| APOE genotype-specific differences in the innate immune response | Q37434999 | ||
| Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients | Q38443652 | ||
| The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge | Q40064649 | ||
| Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. | Q41671941 | ||
| Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture | Q41705313 | ||
| Abnormal contingent negative variation in HIV patients receiving antiretroviral therapy | Q42112369 | ||
| Adaptation of the attention network in human immunodeficiency virus brain injury | Q43489247 | ||
| Does possession of apolipoprotein E ɛ4 benefit cognitive function in healthy young adults? | Q44699908 | ||
| Neural correlates of attention and working memory deficits in HIV patients. | Q45029853 | ||
| Whole brain imaging of HIV-infected patients: quantitative analysis of magnetization transfer ratio histogram and fractional brain volume. | Q45048077 | ||
| Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort | Q45181283 | ||
| Differential effects of the APOE genotype on brain function across the lifespan | Q45239574 | ||
| Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa | Q45373223 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pleiotropy | Q1134884 |
| P304 | page(s) | 1017-1027 | |
| P577 | publication date | 2011-07-21 | |
| P1433 | published in | NeuroImage | Q1981225 |
| P1476 | title | Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging | |
| P478 | volume | 58 |
| Q36345352 | A family history of substance dependence obscures the group differences in brain function associated with HIV-1 and ART. |
| Q37972113 | Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy |
| Q30362822 | Adaptive working memory training improved brain function in human immunodeficiency virus-seropositive patients. |
| Q59357369 | Aging and Apolipoprotein E in HIV Infection |
| Q47630662 | Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals |
| Q24312075 | ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro |
| Q40738269 | Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals |
| Q38435698 | Apolipoprotein E4 Suppresses Neuronal-Specific Gene Expression in Maturing Neuronal Progenitor Cells Exposed to HIV. |
| Q36318703 | Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity |
| Q64882275 | Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy. |
| Q88451436 | Basal ganglia shrinkage without remarkable hippocampal atrophy in chronic aviremic HIV-positive patients |
| Q34247745 | Brain Abnormalities in HIV and Stimulant Users: Interventions and Prevention |
| Q30414573 | Capacity building and collaborative research on cross-national studies in the Asian region |
| Q60417933 | Childhood trauma interacts with ApoE to influence neurocognitive function in women living with HIV |
| Q40290534 | Chronic Tobacco-Smoking on Psychopathological Symptoms, Impulsivity and Cognitive Deficits in HIV-Infected Individuals |
| Q58595914 | Early Introduction of cART Reverses Brain Aging Pattern in Well-Controlled HIV Infection: A Comparative MR Spectroscopy Study |
| Q34389419 | Early suppressive antiretroviral therapy in HIV infection is associated with measurable changes in the corpus callosum |
| Q33961790 | Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits |
| Q57310566 | Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume |
| Q35338414 | Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity |
| Q39527006 | Extracting patterns of morphometry distinguishing HIV associated neurodegeneration from mild cognitive impairment via group cardinality constrained classification |
| Q26865707 | Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder |
| Q36162221 | Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults |
| Q38842237 | Gray matter maturation and cognition in children with different APOE ε genotypes |
| Q27025018 | HIV and aging: effects on the central nervous system |
| Q37354426 | HIV clades B and C are associated with reduced brain volumetrics |
| Q35276630 | HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? |
| Q39423596 | HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis |
| Q33939729 | HIV-associated neurocognitive disorder. |
| Q38809646 | HIV/neuroAIDS biomarkers. |
| Q36520471 | Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females |
| Q35702700 | Human immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration. |
| Q61809971 | Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan |
| Q38930578 | Increased brain-predicted aging in treated HIV disease |
| Q35827867 | Independent effects of HIV, aging, and HAART on brain volumetric measures. |
| Q57816569 | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease |
| Q88638130 | Joint Data Harmonization and Group Cardinality Constrained Classification |
| Q47201399 | Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART. |
| Q37284168 | Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy |
| Q30440212 | Lower cognitive reserve in the aging human immunodeficiency virus-infected brain |
| Q34288457 | Neuroimaging studies of the aging HIV-1-infected brain |
| Q35058529 | No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death |
| Q30938624 | Novel Neuroimaging Methods to Understand How HIV Affects the Brain |
| Q40676918 | Prefrontal cortical thinning in HIV infection is associated with impaired striatal functioning. |
| Q64067089 | Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress |
| Q35953242 | Reduced neural specificity in middle-aged HIV+ women in the absence of behavioral deficits |
| Q59350870 | Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics |
| Q35111027 | Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length |
| Q36849128 | The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons |
| Q64087216 | The Genetic Variability of in Different Human Populations and Its Implications for Longevity |
| Q45542483 | The Metamorphosis of HIV-Associated Neurocognitive Disorders |
| Q47897788 | The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort |
| Q40486706 | The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study |
| Q91604272 | The joint effect of aging and HIV infection on microstructure of white matter bundles |
| Q30410418 | The longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning |
| Q39563761 | Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era. |
| Q35050070 | Verbal memory declines more rapidly with age in HIV infected versus uninfected adults |
Search more.